Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
about
Role of Ca2+ in the control of H2O2-modulated phosphorylation pathways leading to eNOS activation in cardiac myocytesProtein kinase D interacts with neuronal nitric oxide synthase and phosphorylates the activatory residue serine 1412β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.Mammalian enabled (Mena) is a critical regulator of cardiac function.Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis.Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy.Mena/VASP and αII-Spectrin complexes regulate cytoplasmic actin networks in cardiomyocytes and protect from conduction abnormalities and dilated cardiomyopathy.Thioredoxin reductase was nitrated in the aging heart after myocardial ischemia/reperfusion.Cinaciguat prevents the development of pathologic hypertrophy in a rat model of left ventricular pressure overload.VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca(2+) -mediated PKG I pathway.Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.Simvastatin Promotes Cardiac Myocyte Relaxation in Association with Phosphorylation of Troponin I.β1 -adrenergic receptor autoantibodies from heart failure patients enhanced TNF-α secretion in RAW264.7 macrophages in a largely PKA-dependent fashion.Insulin-dependent metabolic and inotropic responses in the heart are modulated by hydrogen peroxide from NADPH-oxidase isoforms NOX2 and NOX4.Protein kinase D activity controls endothelial nitric oxide synthesis.Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection.
P2860
Q28483611-8A261E1D-F8ED-4C11-B1F8-359D9EA026CAQ28537962-1DE98A28-FACE-4B82-B9C3-496B9E4137FAQ34541400-B222A117-E86D-44F2-BF5A-B57BFE6D6AD1Q34979743-273AB91B-A843-4985-A94C-78190EAF232BQ35229424-73B9FDA5-618B-4EC9-82E9-D80839462318Q36281111-F43E7DF3-E4DF-4227-9CE8-9E70F36A3936Q36380981-9C71FFCE-6497-419A-A0AF-91F536601CBAQ37116252-58D7EA64-3EE3-4F25-9A00-6A8383F85070Q37244871-A5D8499B-0628-4942-9D2F-2D0AEB6D6146Q37419185-75FBCEF9-79E4-46E5-B2DF-4C84A3B20F22Q38695797-CAD27302-F23F-4161-8AEF-219F7764D5CFQ38760688-53A6A416-59C1-4633-9E28-AB0FD449EAE8Q38806114-884647AC-AA68-49CF-B335-65DD7BA6B7F1Q39342487-EEF90328-F2D5-493B-BFCF-FA8395A9F704Q46306015-FF4950E7-3860-4563-B123-F829957DFFB6Q50468755-97977D12-A1CE-49BE-88DB-A753FEB4098BQ54338197-0B98D1C1-B74D-4041-8004-59F260BBAA71
P2860
Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of VASP phosphoryla ...... abetic and hypertrophic heart.
@en
Regulation of VASP phosphoryla ...... abetic and hypertrophic heart.
@nl
type
label
Regulation of VASP phosphoryla ...... abetic and hypertrophic heart.
@en
Regulation of VASP phosphoryla ...... abetic and hypertrophic heart.
@nl
prefLabel
Regulation of VASP phosphoryla ...... abetic and hypertrophic heart.
@en
Regulation of VASP phosphoryla ...... abetic and hypertrophic heart.
@nl
P2093
P2860
P1476
Regulation of VASP phosphoryla ...... iabetic and hypertrophic heart
@en
P2093
Benjamin Y Jin
Frank B Gertler
Michael Bauer
Ronglih Liao
Thomas Michel
P2860
P304
P356
10.1152/AJPHEART.00595.2009
P577
2009-09-04T00:00:00Z